Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s David Rosen

Executive Summary

Regulatory counsel/special assistant to Center for Drug Evaluation & Research Director Carl Peck, MD, is leaving the agency Oct. 26 to join the Washington office of the Chicago-based law firm McDermott Will & Emery. Rosen will work in the firm's health section and will focus on drug, biologics and food issues. A commissioned officer in the Public Health Service Corp, Rosen has held numerous positions during his 14 years at FDA. He holds a B.S. in pharmacy and earned a law degree from Catholic University in 1991.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS021525

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel